| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/02/2005 | CN1572792A Pyrazolo [4, 3-d] pyrimidine derivatives |
| 02/02/2005 | CN1572316A Traditional Chinese medicine composition for treating diabetes |
| 02/02/2005 | CN1572304A Medicinal composition for treating diabetes mellitus containing ring Pro |
| 02/02/2005 | CN1572294A Oral gliclazide sustained release formulation |
| 02/02/2005 | CN1572147A Fat or oil composition |
| 02/02/2005 | CN1187450C Method for producing transgenic non-human mammal |
| 02/02/2005 | CN1187370C Connective tissue growth factor fragments and methods and uses thereof |
| 02/02/2005 | CN1187364C 类固醇衍生物 Steroid derivatives |
| 02/02/2005 | CN1187358C Tetrahydro-heterocyclozaepinyl pyrimidine derivatives |
| 02/02/2005 | CN1187354C Adenosine receptor antagonists and methods of making and using the same |
| 02/02/2005 | CN1187336C New imidazole derivatives |
| 02/02/2005 | CN1187330C Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 02/02/2005 | CN1187326C Novel compounds |
| 02/02/2005 | CN1187325C Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof |
| 02/02/2005 | CN1187318C Solid composition suitable for oral administration comprising non hydroscopic salts of L-carnitine or alkanoyl-L-carnitine with 2-aminoethanesulfonic acid |
| 02/02/2005 | CN1187091C Oral vanadium replenishing agent with bimetallic oxide as carrier and its preparation and operation guide |
| 02/02/2005 | CN1187051C Xanthine-based compound for preparation of medicine for enhancing insulin action |
| 02/02/2005 | CN1187043C Food materials useful in preventing and ameliorating metabolic bone diseases and preventives/remedies for metabolic bone diseases comprising these materials |
| 02/02/2005 | CN1187040C Anti-heatstroke effervescent tablet |
| 02/01/2005 | US6849739 N-heterocyclic derivatives as NOS inhibitors |
| 02/01/2005 | US6849733 Compounds containing amidated guanidine derivative type functional group of structure N-C(=N)-N-CO-N-C=N or N-C(=N)-N-CO-N |
| 02/01/2005 | US6849653 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 02/01/2005 | US6849643 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 02/01/2005 | US6849640 Such as 8-(2,4-dichlorophenyl)-2,3,4,4a,5,9b-hexahydro-1H-pyrido(4,3-b)indole for use as HT3 receptor antagonist, for treatment of depression and obesity |
| 02/01/2005 | US6849639 Anticancer agents, antiinflamatory agents, osteoporosis, atherosclerosis |
| 02/01/2005 | US6849638 Phosphodiesterase enzyme 7b (pde7b) inhibitors; treating osteoporosis, osteopenia and asthma |
| 02/01/2005 | US6849636 Useful for treatment of noninsulin-dependent diabetes, hyperglycemia, obesity, insulin resistance, dyslipidemia, hyperlipidemia, hypertension, Metabolic Syndrome |
| 02/01/2005 | US6849635 Sulfonamides |
| 02/01/2005 | US6849629 Heteroaromatic substituted sulfonyl or sulfoxide or thio-pyridazinone derivatives, useful for treating diabetic complications and cardiovascular disorders |
| 02/01/2005 | US6849625 Use in manufacture of a medicament for use as an anti-invasive agent in containment and/or treatment of solid tumor disease |
| 02/01/2005 | US6849622 May be useful for the prophylaxis and treatment of diabetes, particularly type 2 diabetes, and for prophylaxis and treatment of other diseases induced or exacerbated by impaired glucose tolerance |
| 02/01/2005 | US6849621 Treating: allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep |
| 02/01/2005 | US6849595 Calorically dense nutritional composition |
| 02/01/2005 | US6849463 Microarray; diagnostic and detection; storage and protection of chemicals and smaller secondary devices from environmental exposure |
| 02/01/2005 | US6849451 Hybrid cells |
| 02/01/2005 | US6849286 Method for producing a tablet made of isomaltulose, isomalt or isomalt variants |
| 02/01/2005 | US6849257 Comprises catalytic or stoichiometric lipid removal, wherein proteins and/or polypeptides (lysosoymal acid lipase) target receptors in and/or on the cell which lead to uptake into the lysosome |
| 01/27/2005 | WO2005007845A2 Transgenic cells |
| 01/27/2005 | WO2005007838A1 Cell diffrentiation inhibitor, cell culture method using the same, liquid culture medium and cultured cell line |
| 01/27/2005 | WO2005007658A2 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 01/27/2005 | WO2005007647A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 01/27/2005 | WO2005007646A1 Substituted heterocyclic diarylamine analogues |
| 01/27/2005 | WO2005007644A1 Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| 01/27/2005 | WO2005007153A1 A composition of amino acid-iodine complex and methods for preparing and application |
| 01/27/2005 | WO2004104575A3 Diagnostics and therapeutics for diseases associated with x-prolyl aminopeptidase 2 (xpnpep2) |
| 01/27/2005 | WO2004092181A9 Heterocyclic mchr1 antagonists |
| 01/27/2005 | WO2004071218A3 Preparation and food product comprising an active phytase |
| 01/27/2005 | WO2003076565A3 Methods of using 46828, a human acyl-coa synthetase |
| 01/27/2005 | US20050020837 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 01/27/2005 | US20050020684 Modulators of peroxisome proliferator activated receptors |
| 01/27/2005 | US20050020681 Process for producing corosolic acid |
| 01/27/2005 | US20050020668 Combination comprising S-[2-([[1-(2-ethylbutyl)cyclohexyl] carbonyl]amino)phenyl] 2-methylpropanethioate and an HMG CoA reductase inhibitor |
| 01/27/2005 | US20050020661 Antidiabetic agents |
| 01/27/2005 | US20050020652 For example, 2-(4-{2-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-ethoxy}-2-methyl-phenoxy)-2-methyl-propionic acid, 2-(4-{3-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-propyl}-2-methyl-phenoky)-2-methyl-propionic acid; for treating diabetes mellitus |
| 01/27/2005 | US20050020651 Butyric acid derivatives |
| 01/27/2005 | US20050020634 Acat inhibitors; cardiovascular disorders; restenosis; Alzheimer's disease |
| 01/27/2005 | US20050020631 3-Substituted benzofurans as therapeutic agents |
| 01/27/2005 | US20050020624 Dihydroindole and tetrahydroquinoline derivatives |
| 01/27/2005 | US20050020621 Prevent reduced blood flow to brain |
| 01/27/2005 | US20050020618 Antidiabetic agents; obesity |
| 01/27/2005 | US20050020617 3-substituted oxindole beta3 agonists |
| 01/27/2005 | US20050020609 Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
| 01/27/2005 | US20050020606 2,4-Bis (trifluoroethoxy)pyridine compound and drug containing the compound |
| 01/27/2005 | US20050020604 5-HT receptor ligands and uses thereof |
| 01/27/2005 | US20050020602 Bone disorders; reduction concentration of parathyroid hormone in blood |
| 01/27/2005 | US20050020597 Attention deficit disorders; hyperactivity; post-trauma stress disorders; anxiolytic agents; obsessive compulsive disorders; analgesics; Parkinson's disease |
| 01/27/2005 | US20050020585 Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5 |
| 01/27/2005 | US20050020584 Benzamide derivatives as antagonists of orexin receptors |
| 01/27/2005 | US20050020578 Oxidoreductase enzyme inhibitors such as (R)-1-[4-(2-methyl-4-phenyl-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl)-pyrimidin-2-yl-ethanol, used as antidiabetic agents |
| 01/27/2005 | US20050020573 5HT2c receptor modulators |
| 01/27/2005 | US20050020563 Nover diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use |
| 01/27/2005 | US20050020562 Drugs; analgesics; anesthetics; antiarrhythmia agents; antiinflammatory agents ; incontinence; gastrointestinal disorders; neurodegenerative disease |
| 01/27/2005 | US20050020541 Moderate neurotransmitters |
| 01/27/2005 | US20050020540 Biphenylcarboxylic amide derivatives as p38-kinase inhibitors |
| 01/27/2005 | US20050020519 Increase concentration of peptide; controlling glucose uptake into cells; adjust metabolism; stimulate cell proliferation; reduce apoptosis; moderate gene expression' |
| 01/27/2005 | US20050020511 Use of stilbene compounds in preparing medicaments for treating or preventing diabetes and diseases associated with retrovirus |
| 01/27/2005 | US20050020504 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 01/27/2005 | US20050020500 Glycosaminoglycan-polypeptide complex; antiarthritic agents |
| 01/27/2005 | US20050020496 Diagnosis, hormone replacement therapy for HIV positive females, gene therapy; metabolic disorders; antidiabetic, anticholesterol, hypoglycemic agents |
| 01/27/2005 | US20050020484 Using protein mixture of lactoferrin and albumin; anticholesterol agents; antilipemic agents; obesity, hypotensive agents, antidiabetic agents |
| 01/27/2005 | US20050020481 Ion channel modulating compounds and uses thereof |
| 01/27/2005 | US20050019929 Deleted adenovirus vectors and methods of making and administering the same |
| 01/27/2005 | US20050019908 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 01/27/2005 | US20050019854 Analyzing insulin response; solid phase synthesis; for treatment of prediabetes, hyperinsulinemia, and type II diabetes; kits |
| 01/27/2005 | US20050019837 Using glutamate decarboxylase concentration as diagnostic indicator of autoimmune and connective tissue disorders |
| 01/27/2005 | US20050019835 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 01/27/2005 | US20050019826 Peptides blocking vascular endothelial growth factor(vegf)-mediated angiogenesis, polynucleotides encoding said pepetides and methods of use thereof |
| 01/27/2005 | US20050019821 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/27/2005 | US20050019765 Methods for treating disorders of the nervous and reproductive systems |
| 01/27/2005 | US20050019425 Animal feeds contains selenium, for promoting hair growth |
| 01/27/2005 | US20050019390 Dosage system and dosage vehicle therefor |
| 01/27/2005 | US20050019375 Consumable farinaceous food comprising alpha -cyclodextrin and fat having same amounts of calories and cholesterol; reduced bioavailability, increased high density lipoproteins |
| 01/27/2005 | US20050019334 Interleukin antibody or fusion protein; comprising active material and FC domain; Escherichia coli cells |
| 01/27/2005 | US20050019322 Treatment of central nervous system diseases by antibodies against glatiramer acetate |
| 01/27/2005 | US20050019320 Controlling food intake; controlling gene expression of G protein; polypeptide |
| 01/27/2005 | CA2532152A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 01/27/2005 | CA2531401A1 Substituted heterocyclic diarylamine analogues |
| 01/27/2005 | CA2529790A1 Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| 01/27/2005 | CA2525949A1 Transgenic cells expressing proteins involved in fatty acid biosynthesis |
| 01/26/2005 | EP1500656A1 Biguanide derivative and therapeutic agent for diabetes containing the same |